This is supported by neuropathological studies measuring oligomeric tau (MC1+) in AD patients which show that neuronal loss and cognitive deficits correlate with increased MC1 reactivity and that these changes precede NFT formation32. This evidence concerns the gene MAPT and Alzheimer disease.